Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Blackwells Capital Nominates Jessica Schell, Craig Hatkoff and Leah Solivan for Election to the Board of Disney
-
Clubhouse Media Group, Inc. Announces HoneyDrip.com Growth Results For December 2023
-
Fairfax Declares Annual Dividend
-
Form 8.3 - [SMART METERING SYSTEMS PLC - 02 01 2024] - (CGWL)
-
Form 8.3 - [LXi REIT PLC - 02 01 2024] - (CGWL)
-
Sodexo - Monthly disclosure on share capital and voting rights December 31, 2023
-
Arch Biopartners Receives Approval from the Turkish Ministry of Health to Proceed with Phase II Trial for LSALT Peptide Targeting Cardiac Surgery Associated-Acute Kidney Injury
-
SELLAS Provides Corporate Updates and Highlights Key Upcoming Milestones
-
Elektrofi and Janssen Biotech Enter Worldwide Collaboration and License Agreement to Exclusively Develop up to Five Programs Utilizing Elektrofi’s Formulation Technology
-
Papa Johns Brings a New Deal Just to Canada
-
CannaGrow Holdings Subsidiary Acquires License to the Xtreme Fighting Championships (XFC) Brand and Back Catalog
-
Agrify Corporation Announces Results for Third Quarter 2023
-
Optimi Health Granted Precursor Licence To Formulate MDMA And Completes Encapsulation Of 40mg And 60mg Dosage Formats
-
BridgeBio announces FDA clearance of IND application for BBO-8520, a first-in-class direct inhibitor of KRASG12C (ON)
-
Verrica Pharmaceuticals Announces Specialty Pharmacy Partnership Agreement with Walgreens to Distribute YCANTH™
-
HydroGraph’s Graphene Selected by Hawkeye Bio for Use in its Early-Stage Lung Cancer Detection Biosensor
-
Camden National Bank Adopts Advanced Mortgage Origination and Closing Solutions by nCino
-
Anavex to Present at the 42nd Annual J.P. Morgan Healthcare Conference
-
VPG to Present at the 26th Annual Needham Growth Conference on January 18, 2024
-
ABVC BioPharma and its Subsidiary Receive $460M From AiBtl BioPharma as the First Milestone Payment of Global Licensing Fees
-
Rapid Micro Biosystems to Present at 42nd Annual J.P. Morgan Healthcare Conference
-
Microbix Achieves Further QAPs Sales Record
-
Gilat to Participate in the 26th Annual Needham Growth Conference on January 17, 2024
-
BioCryst to Present at 42nd Annual J.P. Morgan Healthcare Conference
-
Kelly Completes Sale of European Staffing Business to Gi Group Holdings S.P.A.
-
Ascot Intercepts High-Grade Gold at the Big Missouri Deposit, Including 58.2 g/t Over 2.0 Metres and 9.9 g/t Over 6.9 Metres
-
Sotera Health to Present at the 42nd Annual J.P. Morgan Healthcare Conference
-
Anfield Prepares For An Increase in Mill Production Capacity With the Acquisition of Additional DOE leases in Colorado
-
BioCardia Biotherapeutic Delivery and Morph Access Innovations Business Development Update for Shareholders
-
POET Technologies Announces ZKTel as Customer and Collaborator
-
InspireMD Announces Appointment of Medical Technology Executive Pete Ligotti as Executive Vice President and General Manager of North America
-
Tango Therapeutics Announces First Patient Dosed in Phase 1/2 Trial of TNG348 in Patients with BRCA1/2-Mutant and Other HRD+ Cancers
-
Liquidity Services Acquires Sierra Auction, a Leading Auctioneer of Vehicles, Equipment, and Surplus Assets for Government and Commercial Organizations
-
Atea Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference
-
Tonix Pharmaceuticals to Present at Two Upcoming Investor Conferences in January: Focus is on TNX-102 SL for the Management of Fibromyalgia Following Positive Topline Results in Second Pivotal Phase 3
-
Troilus Announces Agreement for Strategic Sale of Non-Core Mike Lake Properties in Yukon to Prospector Metals; Retains ~20% Ownership Interest
-
Monte Rosa Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
-
XORTX Submits a New Patent for the Treatment of Chronic Kidney Disease
-
Voyager Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
-
BIMI Announces Results of 2023 Annual General Meeting of Stockholders
-
ProMIS Neurosciences, Inc. Announces Leadership Transition
-
Frontier Medicines to Present at the 42nd Annual J.P. Morgan Healthcare Conference
-
Acreage Enters New York Adult-Use Market with First Wholesale Product Sale
-
Verge Genomics to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 11, 2024
-
Akoustis to Attend CES 2024 Conference in Las Vegas from January 9-12
-
Athira Pharma Completes Enrollment of Phase 2/3 LIFT-AD Clinical Trial of Fosgonimeton in Mild-to-Moderate Alzheimer’s Disease
-
Important Update on Listing Status and Strategic Direction
-
Village Farms International Announces Launch of Top-Selling Cannabis Brands in the UK
-
Apollomics Completes Enrollment in Phase 3 Bridging Study of Uproleselan in Chinese Patients with Relapsed/Refractory Acute Myeloid Leukemia
-
Applied Therapeutics Announces MAA Validation and NDA Submission of Govorestat (AT-007) for Treatment of Classic Galactosemia
